Bedside risk score for medical therapy failure in small-volume BPH: Temporal validation
{{output}}
Purpose: Medical therapy is the first-line treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). However, predictors of treatment failure in men with small prostate volume (
